Page 37 - manuscript_ijb05580

14. Chapman JH, Ghosh D, Attari S, Ude CC, Laurencin CT. Animal Models of Osteoarthritis:
Updated Models and Outcome Measures 2016–2023. Regener. Eng. Transl. Med. 2023;10(2):127-
146. doi:10.1007/s40883-023-00309-x

15. Singh YP, Moses JC, Bhardwaj N, Mandal BB. Overcoming the Dependence on Animal
Models for Osteoarthritis Therapeutics – The Promises and Prospects of In Vitro Models. Adv.
Healthcare Mater. 2021;10(20):2100961. doi:10.1002/adhm.202100961

16. Zhou M, Lozano N, Wychowaniec JK, et al. Graphene oxide: A growth factor delivery
carrier to enhance chondrogenic differentiation of human mesenchymal stem cells in 3D hydrogels.
Acta Biomater. 2019;96:271-280. doi:https://doi.org/10.1016/j.actbio.2019.07.027

17. Ding SL, Zhao XY, Xiong W, et al. Cartilage Lacuna‐Inspired Microcarriers Drive Hyaline
Neocartilage Regeneration. Adv. Mater. 2023;35(30). doi:10.1002/adma.202212114

18. Hwang HS, Kim HA. Chondrocyte apoptosis in the pathogenesis of osteoarthritis. Int. J.
Mol. Sci. Oct 30 2015;16(11):26035-54. doi:10.3390/ijms161125943

19. Ebata T, Terkawi MA, Kitahara K, et al. Noncanonical Pyroptosis Triggered by
Macrophage‐Derived Extracellular Vesicles in Chondrocytes Leading to Cartilage Catabolism in
Osteoarthritis. Arthritis & Rheumatology. 2023;75(8):1358-1369. doi:10.1002/art.42505

20. Maihemuti A, Zhang H, Lin X, et al. 3D-printed fish gelatin scaffolds for cartilage tissue
engineering. Bioact. Mater. 2023;26:77-87. doi:10.1016/j.bioactmat.2023.02.007

21. Korpayev S, Kaygusuz G, Şen M, Orhan K, Oto Ç, Karakeçili A. Chitosan/collagen based
biomimetic osteochondral tissue constructs: A growth factor-free approach. Int. J. Biol. Macromol.
2020;156:681-690. doi:https://doi.org/10.1016/j.ijbiomac.2020.04.109

22. Singh YP, Moses JC, Bandyopadhyay A, Mandal BB. 3D Bioprinted Silk‐Based In Vitro
Osteochondral Model for Osteoarthritis Therapeutics. Adv. Healthcare Mater.
2022;11(24):200209. doi:10.1002/adhm.202200209

23. Salehi S, Brambilla S, Rasponi M, Lopa S, Moretti M. Development of a Microfluidic
Vascularized Osteochondral Model as a Drug Testing Platform for Osteoarthritis. Adv. Healthcare
Mater. 2024;13(31). doi:10.1002/adhm.202402350

24. Ong LJY, Sun AR, Wang Z, Lee J, Prasadam I, Toh YC. Localized Oxygen Control in a
Microfluidic Osteochondral Interface Model Recapitulates Bone–Cartilage Crosstalk During
Osteoarthritis. Adv. Funct. Mater. 2024;34(28):2315608. doi:10.1002/adfm.202315608

25. Wei Y, Deng Y, Ma S, et al. Local drug delivery systems as therapeutic strategies against
periodontitis: A systematic review. J. Controlled Release. 2021;333:269-282.
doi:https://doi.org/10.1016/j.jconrel.2021.03.041

26. Jo YK, Lee D. Biopolymer microparticles prepared by microfluidics for biomedical
applications. Small. 2020;16(9):1903736. doi:https://doi.org/10.1002/smll.201903736

36